May
This is how much saturated fat you can ‘get away’ with eating
A study shows that processes that occur in your heart and blood are the biggest driver in how our bodies use different fats as fuel.
- Boudicca Fox-Leonard
Chemist Warehouse-bound Sigma gets first strike on pay
The drug wholesaler, which is seeking to merge with Chemist Warehouse, will get news on the deal from the ACCC in mid-June.
- Carrie LaFrenz
Fisher & Paykel leaves pandemic behind as respirator demand grows
Earlier this year, Vertium Asset Management’s Jason Teh put the New Zealand-based group on his list of turnaround prospects. Issues at its rival are helping.
- Kylar Loussikian
Healthscope is a fiasco for private debt funds – and their unitholders
In these situations, unitholders typically find out after the fact just how stressed the positions are.
- Sarah Thompson, Kanika Sood and Emma Rapaport
Healius to sell $650m X-ray and ultrasound division after UBS review
The struggling pathology company told investors it had engaged advisers to sell Lumus Imaging as it focuses on reinvigorating its core pathology business.
- Simon Evans
Five V Capital signs $200m-plus Habit Health acquisition
The Sydney-based private equity firm has picked up Livingbridge’s portfolio company for a mid-$200 million figure.
- Sarah Thompson, Kanika Sood and Emma Rapaport
Pharmacy Guild still the natural enemy of competition
The guild’s preferred business model is for its members to be on high margins and their customers paying little, with the taxpayer eternally bridging the difference.
- Myriam Robin
- Exclusive
- Insolvency
Doctors owed millions in collapse of service provider
The Melbourne-headquartered eReports allegedly failed to disclose $7.2 million owed to more than 400 specialists before calling in administrators.
- Max Mason
Biotech start-up raising $20m pre-IPO amid missed payment claims
Plasma start-up Aegros has been accused of not paying suppliers and missing payroll, put is still planning on a 2025 IPO.
- Yolanda Redrup and Carrie LaFrenz
Former Liberal health minister appointed to cancer biotech’s board
Greg Hunt’s new company is developing a cure for a form of myeloma, a rare disease that begins in bone marrow.
- Aaron Patrick
Crescent launches $43m block trade in ClearView Wealth
Stockbroker Morgans Financial was seeking buyers at 59¢ a share or a 1.7 per cent discount to the last traded price.
- Sarah Thompson, Kanika Sood and Emma Rapaport
Fundies have Regis Healthcare founder’s stake on their watch lists
The market has a close eye on founding director Bryan Dorman’s stake in the $1.2 billion aged care provider.
- Sarah Thompson, Kanika Sood and Emma Rapaport
Brookfield’s Healthscope debt trap is a mess for everyone involved
The investment giant is bringing its punchy approach to restructuring – and tactics more often found in the US – to Australia as it works on the hospital group.
- Jemima Whyte
Concussion medtech start-up kicks off raise for US expansion
Headsafe hoping to break into the United States healthcare market with its NuroCHEK device, hitting up early-stage investors for $5 million.
- Sarah Thompson, Kanika Sood and Emma Rapaport
G8 Education board faces investor scepticism over Star links
The biggest for-profit operator of childcare also revealed some problems had struck a controversial deal to offload underperforming centres.
- Liam Walsh
New deal! Five V Capital are creatures of Habit
Allied health providers have proved popular – and profitable – for a number of investors, including Quadrant Private Equity, Next Capital and Adamantem Capital.
- Sarah Thompson, Kanika Sood and Emma Rapaport
Menopause hormone therapy is OK after all, long-term study finds
Since a study in 2002 was called off, women have been reluctant to take hormones. But a new study has reassuring news for women under 60.
- Marlene Cimons
Peloton crashes to record low as CEO quits amid lay-offs
The interactive exercise bike company was a pandemic superstar but is now struggling heavily and laying off 15 per cent of the workforce.
- Mark Gurman
April
- Opinion
- Chanticleer
How Chemist Warehouse can get its deal past the ACCC
Divestments may be needed to get the Chemist Warehouse/Sigma deal over the line, but they don’t look too strenuous.
- Updated
- Anthony Macdonald
Healthscope in $919m writedown as hospital costs jump
One of Australia’s biggest private hospital operators plunged into the red as wage and medical supplies costs climbed, and it booked a big impairment.
- Simon Evans
